Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2025
Сomprehensive approach to comparative characteristics of clinical and laboratory parameters of the study in children - in 6 months after Covid-19 treatment and 6 months after Covid-19 vaccination.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Horlenko Olesya M, Hechko Khrystyna A, Prylypko Lyubomyra B, Hechko Mykhaylo M, Horlenko Fedir V, Galay Bohdan M
Аннотация
OBJECTIVE: Aim: To study and analyze data on clinical and laboratory parameters of investigated children in 6 months after treatment and 6 months after Covid-19 vaccination.
PATIENTS AND METHODS: Materials and Methods: A prospective clinical and laboratory examination of a children group (group 1) with identified Covid-19 (n=68) was carried out in comparison with a group (n=31) of Covid-19 vaccinated children (group 2) after 6 months of observation.
RESULTS: Results: The data of Anti-SARS-CoV-2-S1-RBD IgG, non-significant intergroup differences in levels were found (344.71 ± 87.62 versus 315.67 ± 74.91 BAU/ml, p=0.11). Significant differences were found in the children group who was 6 months after Covid-19 treatment and the control group, as well as in the group before and 6 months after Covid-19 vaccination, in the following parameters: IL-2 (p6<0.01; p7<0.01, with a prevalence of 6 and 4 times, respectively); IL-4 (p6<0.01; p7<0.01with a prevalence of 6 and 4.6 times, respectively), IL-10 (p6<0.01; p7<0.01 with a prevalence of 6 and 4.8 times, respectively), Procalcitonin (p6<0.01; p7<0.01, 18 times and 1.4 times respectively).
CONCLUSION: Conclusions: In our study, according to the data of multivariate linear regression analysis, the level of Anti-SARS-CoV-2-S1-RBD IgG is the dependent variable, and D-dimer, Na level, Total Cholesterol, LF, IL-6, IgG are the influencing factors which determine the COVID-19 anti-infective protection.
PATIENTS AND METHODS: Materials and Methods: A prospective clinical and laboratory examination of a children group (group 1) with identified Covid-19 (n=68) was carried out in comparison with a group (n=31) of Covid-19 vaccinated children (group 2) after 6 months of observation.
RESULTS: Results: The data of Anti-SARS-CoV-2-S1-RBD IgG, non-significant intergroup differences in levels were found (344.71 ± 87.62 versus 315.67 ± 74.91 BAU/ml, p=0.11). Significant differences were found in the children group who was 6 months after Covid-19 treatment and the control group, as well as in the group before and 6 months after Covid-19 vaccination, in the following parameters: IL-2 (p6<0.01; p7<0.01, with a prevalence of 6 and 4 times, respectively); IL-4 (p6<0.01; p7<0.01with a prevalence of 6 and 4.6 times, respectively), IL-10 (p6<0.01; p7<0.01 with a prevalence of 6 and 4.8 times, respectively), Procalcitonin (p6<0.01; p7<0.01, 18 times and 1.4 times respectively).
CONCLUSION: Conclusions: In our study, according to the data of multivariate linear regression analysis, the level of Anti-SARS-CoV-2-S1-RBD IgG is the dependent variable, and D-dimer, Na level, Total Cholesterol, LF, IL-6, IgG are the influencing factors which determine the COVID-19 anti-infective protection.